About this study
We’re currently investigating the effects of a DHA-rich omega-3 powder on cognition, mood and cardiovascular health.
This study involves three visits to the Centre for Human Psychopharmacology over a 1-month period.
You may be eligible for this study if you:
- are male, aged between 40–60 years
- are in good general health
- are a non-smoker
- have no history of other significant medical conditions such as heart disease, diabetes, psychiatric disorders, neurological conditions
- have no fish or milk allergies.
Note: Additional eligibility criteria may apply to participate in this study.
Testing sessions involve computerised cognitive testing and mood questionnaires. Participants will be compensated with $150 for their time.
This trial has finished recruitment and study findings will be available soon.